ReviewCognitive, affective & behavioral neuroscience2025
The neurobiology of love and addiction: Central nervous system signaling and energy metabolism.
Review in Cognitive, affective & behavioral neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stress is inevitable; recovery is conditional: bioenergetic limits of resilience in aging and disease.Biogerontology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite our ongoing fascination with love's pleasures and pain, psychologists and neurobiologists have only recently begun to explore the neurobiological connections shared by feelings of romantic love and the experience of drug addiction. Functional imaging studies have revealed that feelings resulting from romantic love and those resulting from active drug use both activate the central reward system, which is a series of forebrain and midbrain structures that transmit signals primarily via dopamine release. Similarly, the relaxation response, which is a series of behaviors designed to alleviate stress-related physiologic sequelae, may also be helpful as an adjunct therapy for drug withdrawal. The benefits of the relaxation response and related mind-body practices may stem directly from its impact on mitochondria, organelles that are central to balanced energy production. Nitric oxide (NO) is a central neurotransmitter and also a key regulatory molecule that modulates mitochondrial respiration and oxygen utilization. Thus, we propose that observed behaviorally mediated changes that emerge from engaging the relaxation response may be the result of NO-mediated improvements in mitochondrial bioenergetics. Future research might focus on elucidating the important links between cellular bioenergetics, the relaxation response, and the central reward system and might explore NO modulation as a potentially effective target for drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.